MedPath

Influencing Factors and Trigger Mechanism of Relapse in Expectant Fathers Who Quit Smoking

Active, not recruiting
Conditions
Smoking Cessation
Interventions
Other: Questionnaires set
Registration Number
NCT05474651
Lead Sponsor
Sun Yat-sen University
Brief Summary

The purpose of this study is to describe the relapse rate and characteristics of expectant fathers who quit smoking during their wives' pregnancy, to explore the influencing factors and triggering mechanisms,and describe their experience.

Detailed Description

Participants will be invited to recall their smoking status and experience during their wife's pregnancy (all participants and required to complete the questionnaire, and some of them will be invited to participate in semi-structured interviews).

In the quantitative study,participants need to finish the questionnaire,which includes the demographic information sheet, characteristics of smoking sheet, history of smoking cessation sheet, smoking hazard questionnaire, motivation to quit smoking sheet, ability to quit smoking sheet, alcohol consumption, exercise.

In the qualitative study,participants need to participate in semi-structured interview.The interview begins with "Have you tried smoking cessation before? Why? What is the result", and explores in-depth analysis based on the participants' answers.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
294
Inclusion Criteria
  • (1) All participants should be aged 18 or above;
  • (2) The newborn of the participant is alive, and the number of days of birth is ≤28 days;
  • (3) All participants should have actively quit smoking during his wife's pregnancy, and maintained it for at least 24 hours;
  • (4) All participants should be smoking at least 1 cigarette per day on average for at least 1 month in the past 1 year;
  • (5) All participants should be able to communicate in Mandarin (including reading Chinese).
Exclusion Criteria
  • All participants who meet the above criteria but are currently involved in other smoking cessation programs or the pilot study and/or mentally or physically unfit for communication will be excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Questionnaires assessed expectant fathers who quit smokingQuestionnaires setParticipants who met the inclusion criteria below will be invited to fill in the questionnaires set, part of them will be invited to attend a semi-structured interview(optional). 1. Males ≥18 years old; 2. The wife has given birth, the newborn is live, and the number of days of birth is less than or equal to 28 days; 3. Self-reported smoking at least 1 cigarette per day on average for at least 1 month in the past 1 year; 4. Self-reported that they had quit smoking during their wife's pregnancy on purpose, and maintained it for at least 24 hours;
Primary Outcome Measures
NameTimeMethod
Smoking relapse rateBaseline

A true or false sheet in the questionnaire.

Secondary Outcome Measures
NameTimeMethod
Quality of relationshipBaseline

The quality of relationship will be assessed by using the Relationship Satisfaction scale.It includes five items and a six-point response format was used, ranging from 'strongly disagree' to 'strongly agree'.

Dependence of nicotineBaseline

The level of nicotine dependence of the participants will be measured by the Fagerstrom Test of Nicotine Dependence (FTND) scale. The FTND is a standard instrument for assessing the intensity of physical addiction to nicotine.The test was designed to provide an ordinal measure of nicotine dependence related to cigarette smoking. It contains six items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence. In scoring the Fagerstrom Test for Nicotine Dependence, yes/no items are scored from 0 to 1 and multiple-choice items are scored from 0 to 3. The items are summed to yield a total score of 0-10. The higher the total Fagerstrom score, the more intense is the patient's physical dependence on nicotine.

Self-awareness of the hazard of smokingBaseline

The self-awareness of the hazard of smoking among the participants will be measured by a self-designed smoking hazard questionnaire list. The 20-items questionnaire is developed according to the literature review content, focusing on the impact of smoking hazard on maternal and neonate health.Participants were asked to answer whether the knowledge about tobacco harm contained in the entry is correct: yes, no, or don't know (about 20% interference items).The higher the total score,the better the mastery of self-awareness of the hazard of smoking.

Smoking rationalizationBaseline

The smoking rationalization will be measured by a 26-item scale within six dimensions (smoking functional beliefs, risk generalization beliefs, social acceptability beliefs, safe smoking beliefs, self-exempting beliefs, and quitting is harmful beliefs). Each item used a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neither disagree nor agree, 4 = agree, 5 = strongly agree, higher scores represent higher levels of rationalization).

Withdrawal symptomsBaseline

The Cigarette Withdrawal Scale(CWS) is composed of 21 items, including four measuring depression-anxiety, four measuring craving, four measuring irritability-impatience, three measuring concentration difficulties, three measuring appetite-weight gain, and three measuring insomnia. The items were scored using a 5-point Likert-type scale (agree/disagree).

Self-efficacy levelBaseline

Self-efficacy of participants against tobacco will be assessed by using by the Smoking Self-Efficacy Questionnaire(SEQ-12). The SEQ-12 is categorized into two subscales, namely internal stimuli (6 items) and external stimuli (6 items), with total possible scores ranging from 6 to 30 for both internal stimuli and external stimuli. Higher scores of the SEQ-12 on both subscales indicate greater selfefficacy to refrain from smoking.

Trial Locations

Locations (1)

XIAW

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath